Namenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sample packs, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045 NDC 0456-3428-05.
Published February 12, 2014 · Recall initiated: November 13, 2013
Summary
FDA records drug Class III recall D-1065-2014, published February 12, 2014 and initiated November 13, 2013. Recalling firm: Forest Pharmaceuticals Inc; Status: Terminated; Reported quantity: 111,384 sample packs; Lot: Lot 1112467 Exp. 02/15. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Forest Pharmaceuticals Inc
- Distributor
- Nationwide and Puerto Rico.
- Lot
- Lot 1112467 Exp. 02/15
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12 bottles/trays,October 29, 2014
- FDABystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only. ForestJuly 9, 2014
- FDABystolic (nebivolol), 20 mg/tablet, 30 tablets per bottle, Rx only, Licensed from Mylan Laboratories Inc.,May 28, 2014
- FDANamenda XR (memantine HCl), 7 mg extended release capsules, 30-count bottle, Rx only, Forest PharmaceuticalsFebruary 12, 2014
- FDANamenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended release capsules, packagedFebruary 12, 2014
- FDAThe firm is recalling all lots of sterile products compounded by the pharmacy that are within expiry.February 12, 2014
Questions about this recall
Was Namenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sample packs, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045 NDC 0456-3428-05. recalled?
Yes. FDA published recall D-1065-2014 on February 12, 2014. Reported hazard: Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter